Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06572410 · ClinicalTrials.gov registry record
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision
A clinical trial of Tumors, Breast, sponsored by Elucent Medical.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06572410: Recruiting study of Tumors, Breast, sponsored by Elucent Medical.
NCT06572410 is a study of Tumors, Breast that is actively recruiting participants, run by Elucent Medical. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06572410, a study of Tumors, Breast, is actively recruiting participants, sponsored by Elucent Medical.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational study. The purpose of this study is to evaluate the use of real-time surgical navigation for the localization and surgical removal of soft tissue tumors. The goal is to collect information about the efficiency and effectiveness of the EnVisio Surgical Navigation for intraoperative guidance to obtain negative margin on initial specimen. Prospective Patient Study: 200 consecutive patients
Conditions Studied
Interventions
- DEVICE EnVisio Navigation System
Study Locations (1)
Florida
- Advent Winter Garden - Winter Garden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-08-07 |
| Est. Completion | 2026-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06572410
The ClinicalTrials.gov registry entry for NCT06572410 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Elucent Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tumors, Breast appearing as the primary indexed condition, and to 1 intervention - of which EnVisio Navigation System is the first listed.
NCT06572410 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06572410 about?
NCT06572410 is a clinical study titled "Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision". Observational study. The purpose of this study is to evaluate the use of real-time surgical navigation for the localization and surgical removal of soft tissue tumors. The goal is to collect information about the efficiency and effectiveness of the EnVisio Surgical Navigation for intraoperative guid...
What is the current status of trial NCT06572410?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-08-07. Estimated completion is 2026-02-15.
What conditions does trial NCT06572410 study?
This clinical trial studies the following conditions: Tumors, Breast.
What interventions are being tested in trial NCT06572410?
The interventions under investigation include: EnVisio Navigation System (DEVICE).
Who is sponsoring clinical trial NCT06572410?
This trial is sponsored by Elucent Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06572410 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tumors, Breast
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.